Omnicell Profit Margin 2006-2019 | OMCL

Current and historical gross margin, operating margin and net profit margin for Omnicell (OMCL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Omnicell net profit margin as of March 31, 2019 is 4.74%.
Omnicell Annual Profit Margins
Omnicell Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.343B $0.787B
Omnicell, Inc. is a leading provider of medication and supply management automation, analytics software, and medication adherence solutions for healthcare organizations. It works with healthcare providers to drive operational efficiency by removing tedious tasks and waste. Regardless of distribution model, their solutions automate manual processes-including ordering, receiving, stocking, and picking medications. At Omnicell, delivering their technology is just the beginning. Omnicell Inc., is also committed to delivering the best customer experience. To ensure their customers gain the most utility from their Omnicell systems, the Company offers a comprehensive training and education program and first-rate customer support.
Stock Name Country Market Cap PE Ratio
Cerner (CERN) United States $22.971B 31.23
Medidata Solutions (MDSO) United States $5.709B 100.77
INC Research Holdings (SYNH) United States $4.404B 16.39
HMS Holdings Corp (HMSY) United States $2.649B 32.35
Allscripts Healthcare Solutions (MDRX) United States $1.696B 19.60
IRHYTHM TECH (IRTC) United States $1.694B 0.00
Invitae (NVTA) United States $1.566B 0.00
Inspire Medical Systems (INSP) United States $1.285B 0.00
NEXTGEN HEALTHCARE, INC (NXGN) United States $1.252B 35.18
Tabula Rasa Healthcare (TRHC) United States $0.964B 219.15
Axonics Modulation Technologies (AXNX) United States $0.893B 0.00
111 Sponsored ADR (YI) China $0.698B 0.00
Computer Programs And Systems (CPSI) United States $0.382B 15.75
Senseonics Holdings (SENS) United States $0.357B 0.00
FULGENT GENETIC (FLGT) United States $0.107B 0.00
Itamar Medical Sponsored ADR (ITMR) $0.091B 0.00
Motus GI Holdings (MOTS) United States $0.072B 0.00
NantHealth (NH) United States $0.066B 0.00
Strata Skin Sciences (SSKN) United States $0.063B 0.00
Medical Transcription Billing (MTBC) United States $0.060B 0.00
Transgenomic (PRPO) United States $0.035B 0.00
Streamline Health Solutions (STRM) United States $0.029B 0.00
Digirad (DRAD) United States $0.013B 0.00